alzheimer-s-disease

Documents about alzheimer-s-disease

• Overcoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease#4528Europe PMC
• Signaling cascades shape functional subpopulations of cortical astrocytes in male wild-type mice and APP/PS1dE9 Alzheimer’s disease model#14159HAL (France)
• Divergent patterns of cognitive decline in preclinical Alzheimer's disease: Implications for secondary prevention trials#125782Europe PMC
• Neuroimaging in dementia and Alzheimer's disease: Current protocols and practice in the Republic of Ireland#186496Research Repository UCD
• The effect of canagliflozin on hippocampal dendrite morphology in a model of Alzheimer's disease induced by intracerebroventricular injection of streptozotocin#312253Muğla Sıtkı Koçman University Institutional Repository
• Detecting Alzheimer’s Disease through Chinese Speech: A Contrast of Manual and Automatic Linguistic Feature Extraction#368857OSF
• Low Sensitivity of Neuropsychological Scales Hinder Detection of Potential Benefit of Treatments in Alzheimer's Disease: A Position Paper#5557Europe PMC
• Solvation-Guided Design of Fluorescent Probes for Discrimination of Amyloids#492062eScholarship
• Thalamic nuclei insights into Alzheimer's disease#314144bioRxiv / medRxiv
• Quantitation of Spatial Proteoforms in Alzheimer's Disease#422359bioRxiv / medRxiv
• Baseline FDG-PET Brain hypometabolism as a predictive biomarker of cognitive decline and Alzheimer's disease risk#182055Europe PMC
• Comparative Analysis of Deep Learning Techniques in Alzheimer's Disease Diagnosis: Trends, Challenges, and Future Directions#205465Europe PMC
• Selective reduction of KCNA4 in vulnerable glutamatergic-serotonin neurons of the dorsal raphe nucleus in Alzheimer's disease#212948Europe PMC
• The impact of the interaction between SIRT1 and lifestyle factors on Alzheimer’s disease risk and related phenotypes#223394Research Online
• Multimodal Machine Learning for Alzheimer's Disease Classification Using ADNI Biomarker Fusion#396647ODU Digital Commons
• Intersection Of Capacity Law And Neurodegenerative Disease With A Focus On Alzheimer’s Medication#401534EliScholar
• Cardiovascular risk and hippocampal-cognitive coupling in Alzheimer's disease#332446bioRxiv / medRxiv
• Repurposing FDA-approved drugs as multi-target neuroprotective agents for Alzheimer's disease via computational screening and experimental validation#5503Europe PMC
• Physical Exercise and Mechanism Related to Alzheimer’s Disease: Is Gut–Brain Axis Involved?#197444Repositorio UNAB
• Tracking of Neuroinflammation Dynamics During Combined Anti-β-Amyloid Therapy (AAT) and Immunomodulation in a Preclinical Alzheimer’s Disease Model#231289Europe PMC
• Cerebrospinal Fluid Markers of Alzheimer’s Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer’s Disease#384127CiNii
• Plain language summary: the evoke(+) studies of semaglutide for early Alzheimer's disease#642368Europe PMC
• CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study#202760IRIS
• Mapping individual molecular connectomes in Alzheimer's disease.#123051NCBI PubMed Central
• Immune receptor LAG3 regulates microglia function during Alzheimer’s disease#217724Europe PMC
• Tau-Connectome Predictive Modeling and Subtyping in Preclinical Alzheimer's Disease#256630EliScholar
• Stress, stress systems, and Alzheimer's disease.#265469NCBI PubMed Central
• Exploring longitudinal relationships among Alzheimer's disease biomarkers.#420892NCBI PubMed Central
• Simulated shared and supported decision making for amyloid immunotherapy in Alzheimer's disease: A bicentric study#8270HAL (France)
• Early metabolic changes in the brain of Alzheimer’s disease rats are driven by GLAST+ cells#274375HAL (France)
• Table 1_Dynamic changes of gut microbiota during progression of three Alzheimer’s disease mice models.xls#300637Figshare
• Identifying the determinants of hospital readmission in dementia patients – A retrospective cohort study using electronic healthcare records in England#372107PLOS
• Measuring Proteostasis Changes in Apolipoprotein E Mouse Models Using Quantitative and Kinetic Proteomic Methods#623366BYU ScholarsArchive
• AI-enabled in silico immunohistochemical characterization for Alzheimer's disease#492074eScholarship
• Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results#184992Dipòsit Digital de la Universitat de Barcelona
• The Role of Verbal Memory in Masking Symptoms of Alzheimer's Disease#13909bioRxiv / medRxiv
• Restoring Theta–Gamma coupling in Alzheimer's disease: Toward network-based neuromodulation.#30688NCBI PubMed Central
• The YTHDF proteins shape the brain gene signatures of Alzheimer's disease#290724bioRxiv / medRxiv
• Greater Amyloid Burden in Cognitive Networks in Preclinical Alzheimer's Disease#310915bioRxiv / medRxiv
• <i>Blautia coccoides</i>-derived metabolite trimethylamine-N-oxide exacerbates Alzheimer's disease progression via targeting HIF1α signaling#5183Europe PMC
• Predictive Genetic Testing for Alzheimer's Disease in Long-Term Care Insurance#167578Digital Commons @ University of Georgia School of Law
• The Role of Magnetic Resonance Spectroscopy (MRS), Diffusion-Tensor-Imaging (DTI) and Structural MRI in the Alzheimer's Disease and Mild Cognitive Impairment Diagnosis: A Review#253598Europe PMC
• Computational Analysis of FDA-Approved Drugs for Potential Repurposing in Alzheimer's Disease: Targeting mTOR and NGFR Pathways#320931SWU eJournals System
• Functionally informed annotation influences pathway-specific polygenic risk and disease inference in Alzheimer's disease#307249bioRxiv / medRxiv
• From correlation to causation: cell‐type‐specific gene regulatory networks in Alzheimer's disease#609465eScholarship
• The GPCR Connection: Linking Alzheimer's Disease and Glioblastoma.#3727NCBI PubMed Central
• Single-Nuclei Transcriptomic Characterization of APOE4-Associated Alzheimer's Disease#151551bioRxiv / medRxiv
• Hyperglycosylation is a metabolic driver of Alzheimer's disease.#317680NCBI PubMed Central
• Cross entropy gradient analysis for Alzheimer's disease assessment.#362112NCBI PubMed Central
• Effects of Hypoperfusion in Alzheimer's Disease#384150CiNii